SK Partners - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 1,873,667 | 1,007,988 | 1,826,397 | 508,564 | 402,122 | 493,994 | 579,248 | 685,707 |
| Profit before tax | 260,500 | 195,656 | 261,887 | - | 213,444 | 153,419 | 77,089 | 182,502 |
| Net profit | 217,250 | 171,506 | 197,948 | 15,446 | 197,005 | 130,248 | 45,162 | 131,059 |
| Equity | 1,583,335 | 1,754,841 | 2,152,789 | 1,815,295 | 1,485,870 | 1,616,118 | 1,661,280 | 3,707,220 |
| Liabilities | 1,511,463 | 1,082,474 | 1,131,536 | 719,544 | 899,416 | 1,195,092 | 1,646,500 | 1,645,470 |
| Non-current assets | 1,285,845 | 1,237,877 | 1,053,704 | 987,048 | 11,875 | 19,842 | 1,027,878 | 1,656,090 |
| Current assets | 1,805,731 | 1,598,030 | 2,228,739 | 1,546,955 | 2,372,407 | 2,789,124 | 2,277,818 | 3,696,600 |
| Total assets | 3,091,576 | 2,835,907 | 3,282,443 | 2,534,003 | 2,384,282 | 2,808,966 | 3,305,696 | 5,352,690 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 3,677 | 13,294 | 69,831 |
|
Financial indicators
|
||||||||
| Revenue change y/y | -19.6% | -46.2% | +81.2% | -72.2% | -20.9% | +22.8% | +17.3% | +18.4% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 7.0% | 6.0% | 6.0% | 0.6% | 8.3% | 4.6% | 1.4% | 2.4% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 13.7% | 9.8% | 9.2% | 0.9% | 13.3% | 8.1% | 2.7% | 3.5% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 11.6% | 17.0% | 10.8% | 3.0% | 49.0% | 26.4% | 7.8% | 19.1% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 13.9% | 19.4% | 14.3% | - | 53.1% | 31.1% | 13.3% | 26.6% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 1.0 | 0.6 | 0.5 | 0.4 | 0.6 | 0.7 | 1.0 | 0.4 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 803,012 | 335,996 | 608,799 | 169,521 | 134,041 | 164,665 | 239,686 | 342,854 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
SK Partners - Social security debts
The company had no debts to Sodra
SK Partners - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-02-20 | 2025-02-24 | 13.0 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
SK Partners, UAB (code 300851783) is a Private Limited Liability Company engaged in the wholesale of pharmaceutical and medical goods. In 2025, the company generated revenue of €685.7K, up 18.4% year on year and 38.8% over two years. Net profit reached €131.1K, after €45.2K in 2024 and €130.2K in 2023, showing a temporary dip in 2024 followed by a strong recovery in 2025. Profit margin improved to 19.1% in 2025 from 7.8% in 2024 and 26.4% in 2023. The balance sheet expanded further, with total assets increasing to €5.35M in 2025 from €3.31M in 2024 and €2.81M in 2023. Equity rose to €3.71M, while liabilities remained at €1.65M, lifting the equity ratio to 69.3% and keeping debt-to-equity at 0.44. Long-term assets increased to €1.66M, while short-term assets were €3.70M. Return on equity stood at 3.5% and return on assets at 2.5%. Revenue per employee was €342.9K, with profit per employee of €65.5K, indicating solid operational productivity.